MARKER THERAPEUTICS, INC. Interest on Convertible Debt, Net of Tax
MARKER THERAPEUTICS, INC. (MRKR) reported Interest on Convertible Debt, Net of Tax of $0 for the 3-month period ending 2015-06-30, per its 10-Q/A filed 2016-04-14.
Discontinued › Notes › Earnings Per Share
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2016-04-14
- MARKER THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2015-06-30 was $0.00.
- MARKER THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2014-12-31 was $984.59K.
- MARKER THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2014-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. interest on convertible debt, net of tax for the quarter ending 2014-06-30 was -$8.66K.
- MARKER THERAPEUTICS, INC. interest on convertible debt, net of tax for fiscal 2014 was $492.30K.
| Period end | Interest on Convertible Debt, Net of Tax 3 month | Interest on Convertible Debt, Net of Tax 6 month | Interest on Convertible Debt, Net of Tax 9 month | Interest on Convertible Debt, Net of Tax 12 month |
|---|---|---|---|---|
| 2015-06-30 | $0.00 10-Q/A · filed 2016-04-14 | $0.00 10-Q/A · filed 2016-04-14 | ||
| 2014-12-31 | $984.59K derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-04-14 | $984.59K derived: sum of 2 quarters · filed 2016-04-14 | $975.93K derived: sum of 3 quarters · filed 2016-04-14 | $492.30K 10-K · filed 2016-04-14 |
| 2014-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2016-04-14 | -$8.66K derived: sum of 2 quarters · filed 2016-04-14 | -$492.30K 10-Q/A · filed 2016-04-14 | |
| 2014-06-30 | -$8.66K 10-Q/A · filed 2016-04-14 | -$492.30K 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |